Enhancing drug administration in Drosophila melanogaster: a method for using solid dispersions for improved...

Area of Science:

• Biomedical research
• Toxicology
• Pharmacology

Background:

• Drosophila melanogaster is a key model organism for studying human diseases.
• Administration of hydrophobic compounds in Drosophila is challenging, limiting toxicological and behavioral studies.

Purpose of the Study:

• To develop a general method for preparing and administering hydrophobic compounds to Drosophila melanogaster.
• To improve the solubility and bioavailability of hydrophobic compounds for research.

Main Methods:

• Preparation of PEG 8000-based solid dispersions for hydrophobic compounds (DSG, geldanamycin, RU486).
• In vitro validation of solubility using Nuclear Magnetic Resonance (NMR) spectroscopy.
• Administration via subcutaneous injections, solid food mixing, and Capillary Feeder Assay (CAFE).

Main Results:

• PEG 8000 solid dispersions increased aqueous solubility of hydrophobic compounds.
• PEG did not adversely affect Drosophila survival, unlike DMSO.
• PEG-RU486 formulation demonstrated enhanced bioavailability compared to ethanol-dissolved RU486.

Conclusions:

• The developed method offers an effective way to administer hydrophobic compounds to Drosophila.
• This technique facilitates toxicological and behavioral studies in Drosophila melanogaster.
• PEG solid dispersions are a promising approach for improving hydrophobic drug delivery in model organisms.